You are holding the pen for the first time. You have read the leaflet twice, scrolled through more online stories than you can count, and you are feeling two things at once: hopeful, and unsure. Have I made the right decision? Will it work for me? Am I doing this correctly?
If that is where you are, you are in good company. Most people starting Mounjaro feel a mix of excitement and nerves, and many search for a week-by-week account because they want to know what is coming rather than guess at it.
This guide walks through the early stages of treatment as a clinician would explain them, week by week through your first month. It is written for reassurance through understanding, not to set a target you must hit.
One point matters before we begin. Mounjaro is a prescription-only medicine, and everyone responds differently. Weight loss varies between patients. Side effects vary between patients. The timeline below is a general picture, not a promise, and a clinical review with your prescriber is an important part of treatment. Use this as a map of the territory, not a guarantee of the route.
Week 1: Getting Started
The first week is about learning, not results.
Your first injection of Mounjaro is given once weekly, and most people start on the lowest dose of 2.5mg. This starting dose is designed to help your body adjust rather than to drive weight loss, so it is worth setting that expectation early. The first job is building a routine: choosing a consistent day, learning the injection technique your clinician has shown you, and storing the pen correctly.
Many people notice a change in appetite in the first days or weeks. Food can feel less interesting, portions that once seemed normal can feel like too much, and the constant pull towards snacks may ease. This varies a great deal between individuals, and some people notice very little at first.
Early side effects are common as the body adjusts. In the SURMOUNT-1 trial, the most frequently reported side effects were nausea, affecting around 29% of participants, diarrhoea at around 23%, and constipation at around 17%. These were most often mild to moderate and tended to occur as the dose was introduced or increased.
It is worth saying clearly: not everyone experiences side effects, and those who do will not necessarily have all of them. If anything feels severe or concerning, contact your prescriber rather than pressing on alone.
Week 2: Building Confidence
By the second week, the pen tends to feel less daunting.
The injection that felt clinical and unfamiliar in week one usually becomes a quick, manageable part of the week. Confidence grows with repetition, and many people find the routine settles into the background of normal life.
Appetite changes may become more noticeable for some, though again this differs from person to person. People often describe a quieter relationship with food: fewer cravings, less mental chatter about the next meal, and feeling satisfied sooner.
This is a useful week to pay attention to food awareness rather than rules. Noticing real hunger versus habit, eating slowly, and keeping protein and fluids up can help you work with the medication rather than against it. None of this guarantees a particular outcome, but it supports the adjustment your body is making.
Week 3: Settling Into Treatment
The third week is often where things steady.
For many people, the body has begun to adapt to the medication, and any early side effects often stabilise or ease. That is not universal, and some people take longer to settle, but the sharp newness of the first fortnight usually softens.
This is the point at which habits start to matter more than novelty. Regular meals, sensible hydration, gentle activity and consistent injection timing all build the foundation for the longer term. Tirzepatide acts on appetite regulation; the habits built around treatment are part of how it is intended to be used over time.
If side effects are still troublesome at this stage, that is worth raising at your review rather than enduring quietly. Management is often possible, and your clinician can advise.
Week 4: The End Of Your First Month
The first month closes with a sensible question: how has it gone?
This is a natural moment for a clinical check-in. For patients treated in Ashford, that review is carried out locally with the Independent Prescriber who started your treatment, rather than at a distance. Your prescriber will look at how you have tolerated the starting dose, any side effects, and how you are feeling overall. A review like this is not a formality; it is how treatment stays safe and tailored to you.
Most patients begin on 2.5mg and stay there for the first four weeks. From there, the dose may be increased gradually, under clinician guidance, following a typical escalation pathway:
2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
Each step up is a clinical decision, not an automatic one. Doses are increased only when appropriate for you, and not everyone reaches the highest dose. The aim is the lowest dose that helps you while keeping side effects manageable, which is a balance your prescriber will judge with you.
Why The First Month Isn’t The Whole Story
If there is one thing worth holding onto, it is this: the first month is the beginning of treatment, not a verdict on it.
The 2.5mg starting dose is an introductory step. It is designed to help your body adjust to the medication, not to drive weight loss, so reading too much into the first four weeks can be misleading. Treatment with Mounjaro develops over months, not weeks, and the dose is increased gradually under clinician guidance as part of that process.
The well-known trial figures make the point. The average results reported in SURMOUNT-1 were measured over 72 weeks, not the first month. Dose escalation across that period is part of how those outcomes were reached, which is why a steady, reviewed approach matters more than a fast one.
Early patience tends to be rewarded with a clearer picture. None of this means a particular result is assured; individual experiences and weight loss vary between patients, and some people respond differently from others. The Ashford patients who settle in best are often those who treat the first month as a foundation and lean on their reviews rather than the scales. Whether treatment is working for you is a question for your prescriber at your follow-up, not for week one.
What Weight Loss Clinical Trials Actually Show
It helps to separate the first month from the long-term evidence, because they are not the same thing.
The headline figures people read about come from clinical trials that ran over many months, not four weeks. In the SURMOUNT-1 trial, participants taking tirzepatide (the active ingredient in Mounjaro) over 72 weeks saw an average weight reduction of 20.9%. In the same trial, 91% of participants lost at least 5% of their body weight, and 57% lost at least 20%.
Longer-term follow-up has reported sustained average weight loss of around 22.9% over three years. A separate head-to-head trial, SURMOUNT-5, compared tirzepatide with semaglutide (the active ingredient in Wegovy). It reported average weight loss of 20.2% in the tirzepatide group and 13.7% in the semaglutide group, a relative difference of around 47%.
These are group averages from a clinical trial, reported here as factual findings. They do not indicate which medicine is appropriate for any individual. Choosing between treatments is a clinical decision made with a prescriber, based on your health, history and circumstances, not on trial figures alone.
These numbers are worth understanding for what they are: averages from large groups over long periods. They are not first-month expectations, and they are not a forecast of your individual result. Weight loss varies between patients, and trial averages cannot tell any one person what they will experience. Your own journey will be shaped by your starting point, your health, your response to the medication and the habits you build alongside it.
Common Side Effects During The First Month
Most early side effects are digestive, and most are mild to moderate. Knowing how to manage them makes the first month more comfortable.
Nausea is the most commonly reported. Eating smaller, slower meals, avoiding very rich or fatty food, and stopping when you feel full can help. Bland foods are often easier on settling days.
Diarrhoea can occur as the body adjusts. Staying well hydrated matters, and it is worth keeping fluids up across the day rather than in large amounts at once.
Constipation is also common and pulls in the opposite direction. Fibre, fluids and gentle movement can help keep things regular.
These suggestions are general comfort measures, not medical advice for your specific situation. If side effects are severe, persistent, or include anything beyond the digestive symptoms above, contact your prescriber. Side effects vary between patients, and a clinical review is the right place to address them.
Why Patients Often Say “I Should Have Done This Sooner”
One reflection comes up more than any other once people are a few weeks in. It is rarely about the number on the scales. It is about feeling differently around food.
People often describe less preoccupation with the next meal and fewer cravings to manage, alongside a sense of more settled choices around food. For some, that shift is the first time in a long while that eating has felt less like a daily struggle.
That is often where the reflection surfaces. Patients look back at weeks or months of putting it off, of assuming they should manage on willpower alone, and reflect that they wish they had looked into it sooner. We share these as common observations, not as a promised outcome. Every patient is different, results vary, and the right path for you is something to discuss with a clinician rather than assume from someone else’s story.
If you have been hesitating, that hesitation is normal. The point of understanding the early stages is to replace the unknown with a realistic picture, so any decision you make is an informed one.
Why Ashford Patients Choose Easy Clinic
Starting a treatment like this is easier with a clinician you can talk to.
Easy Clinic is based in Ashford, Surrey, and treatment is led by an Independent Prescriber on site, which means assessment, prescribing where appropriate, and follow-up happen with a qualified prescriber rather than at a distance. The clinic is GPhC registered, has been established since 2008, and has cared for over 1,000 patients across a range of services. No GP referral is required to arrange an initial assessment.
What matters most is the clinical conversation. Mounjaro is not suitable for everyone, and a proper assessment looks at your health, your history and whether treatment is appropriate for you. That assessment, and the reviews that follow, are central to safe care rather than an optional extra.
Frequently Asked Questions
How quickly does Mounjaro start working?
Many people notice appetite changes within the first days or weeks, though this varies between individuals. Meaningful changes in weight tend to develop gradually over months rather than in the first week, and the starting dose is set low to help your body adjust.
What happens in the first week of Mounjaro?
The first week centres on starting the lowest dose, learning the once-weekly injection routine, and noticing any early appetite changes or side effects. It is an adjustment period rather than a results period.
Do side effects improve?
For many people, early digestive side effects ease or stabilise after the first few weeks as the body adapts. This is not universal, and side effects vary between patients. Anything severe or persistent should be raised with your prescriber.
When do people increase their dose?
Most patients stay on 2.5mg for the first four weeks, after which the dose may be increased gradually under clinician guidance. Each increase is a clinical decision based on how you are tolerating treatment, and not everyone reaches the highest dose.
How much weight do people lose in the first month?
There is no set figure, and the first month is mainly about adjusting to the medication rather than reaching a weight-loss milestone. The well-known trial averages reflect long-term outcomes over many months, not the first four weeks, and individual results vary.
What if I miss a dose?
Guidance depends on how long it has been since the missed dose. Follow the advice in your medication leaflet and contact your prescriber or clinic if you are unsure rather than guessing or doubling up.
A Realistic Next Step
The early weeks of Mounjaro are less dramatic than the online stories suggest and more reassuring than the worry that precedes them. The first month is about starting low, learning the routine, managing any side effects, and reviewing progress with a clinician, while the well-known results build over much longer periods.
If you have been weighing it up, the value of understanding what to expect is that it turns a leap into an informed step. Whether Mounjaro is right for you is a question for a clinical assessment, where your health and history can be considered properly.
To arrange an assessment, contact Easy Clinic in Ashford, Surrey. Treatment is led by an Independent Prescriber, the clinic is GPhC registered, has been established since 2008, and has cared for over 1,000 patients. Individual results vary, and a clinical review is an important part of safe treatment.
Ready to take the next step?
Book your consultation with Easy Pharmacy in Surrey. Same-day and next-day appointments usually available.
